Back HIV/AIDS

HIV / AIDS

New HIV Diagnoses Stable In Western Europe, Rising in Central and Eastern Europe

The annual surveillance report recently released by the European Centre for Disease Prevention and Control (ECDC) shows that the number and rate of new diagnoses of HIV is continuing to rise in Eastern Europe, and is also rising sharply, though from a much lower base, in Central Europe. Meanwhile, the annual number of new diagnoses is stable in Western Europe, but continues to increase among gay men and other men who have sex with men (MSM) in most Central European and Western European countries.

alt

Top 10 HIV and Hepatitis Stories of 2015

Antiretroviral treatment for everyone living with HIV, expansion of pre-exposure prophylaxis (better known as PrEP) for HIV prevention, and access to interferon-free therapies for hepatitis C topped the HIV and viral hepatitis headlines this year and will continue to be major issues going into 2016. Here's a look back at some of our biggest news from 2015.

alt

4. Getting to Zero -- Progress Toward Ending HIV Epidemic

In July UNAIDS released a report showing that the Millennium Development Goal of getting 15 million people with HIV worldwide onto antiretroviral therapy (ART) by 2015 -- a goal many once considered impossible -- had been reached 9 months sooner than projected. Other targets have also been achieved or exceeded, as new HIV infections have decreased by 35% and AIDS-related deaths by 41%.

alt

2. More Evidence Shows PrEP Is Highly Effective

Pre-exposure prophylaxis (PrEP) was again a major HIV story in the mainstream media in 2015, amid growing evidence that it is highly effective both in research studies and in real-world practice when taken consistently.

alt

5. Indiana HIV Outbreak Linked to Opioid Injection

In January the Indiana State Department of Health and the Centers for Disease Control and Prevention (CDC) began investigating an outbreak of HIV in rural Scott County, near the Kentucky border. The CDC issued an official health advisory in April, and CDC and Indiana investigators published a report in the May 1 edition of Morbidity and Mortality Weekly Report.

alt

1. Treat Everyone Living with HIV

In September the World Health Organization released updated guidelines calling for antiretroviral therapy (ART) for everyone diagnosed with HIV regardless of CD4 T-cell count, as well as pre-exposure prophylaxis for people at substantial risk of infection. WHO estimates that the recommendations, if widely adopted, could avert 21 million deaths and prevent 28 million new infections worldwide by 2030.

alt

6. New TAF Version of Tenofovir Approved in Combo Pill

In November the U.S. Food and Drug Administration announced the approval of Gilead Sciences' Genvoya, a new single-tablet regimen containing the integrase inhibitor elvitegravir, the booster cobicistat, emtricitabine, and tenofovir alafenamide or TAF -- a new formulation that is easier on the kidneys and bones than the older tenofovir disoproxil fumarate (TDF).

alt